Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

301 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Prostate-specific membrane antigen.
Fair WR, Israeli RS, Heston WD. Fair WR, et al. Prostate. 1997 Jul 1;32(2):140-8. doi: 10.1002/(sici)1097-0045(19970701)32:2<140::aid-pros9>;2-q. Prostate. 1997. PMID: 9215402 Review.
Detection of bladder carcinoma in females by flow cytometry and cytology.
Hermansen DK, Badalament RA, Fair WR, Kimmel M, Whitmore WF Jr, Melamed MR. Hermansen DK, et al. Among authors: fair wr. Cytometry. 1989 Nov;10(6):739-42. doi: 10.1002/cyto.990100611. Cytometry. 1989. PMID: 2582965
Clinical significance of small (less than 0.2 cm3) hypoechoic lesions in men with normal digital rectal examinations and prostate-specific antigen levels less than 10 ng/mL.
Fleshner NE, O'Sullivan M, Premdass C, Fair WR. Fleshner NE, et al. Among authors: fair wr. Urology. 1999 Feb;53(2):356-8. doi: 10.1016/s0090-4295(98)00509-3. Urology. 1999. PMID: 9933054
The TNM classification of prostate cancer.
Schröder FH, Hermanek P, Denis L, Fair WR, Gospodarowicz MK, Pavone-Macaluso M. Schröder FH, et al. Among authors: fair wr. Prostate Suppl. 1992;4:129-38. doi: 10.1002/pros.2990210521. Prostate Suppl. 1992. PMID: 1574453 Review. No abstract available.
Phase II evaluation of coumarin (1,2-benzopyrone) in metastatic prostatic carcinoma.
Mohler JL, Gomella LG, Crawford ED, Glode LM, Zippe CD, Fair WR, Marshall ME. Mohler JL, et al. Among authors: fair wr. Prostate. 1992;20(2):123-31. doi: 10.1002/pros.2990200208. Prostate. 1992. PMID: 1549551 Clinical Trial.
Prognostic significance of antigenic heterogeneity, Gleason grade, and ploidy of lymph node metastases in patients with prostate cancer.
Bazinet M, Hamdy SM, Bégin LR, Stephenson RA, Fair WR. Bazinet M, et al. Among authors: fair wr. Prostate. 1992;20(4):311-26. doi: 10.1002/pros.2990200406. Prostate. 1992. PMID: 1376912
Regression of bladder tumors in mice treated with interleukin 2 gene-modified tumor cells.
Connor J, Bannerji R, Saito S, Heston W, Fair W, Gilboa E. Connor J, et al. J Exp Med. 1993 Apr 1;177(4):1127-34. doi: 10.1084/jem.177.4.1127. J Exp Med. 1993. PMID: 8459207 Free PMC article.
Immunopathologic analysis of human urinary bladder cancer. Characterization of two new antigens associated with low-grade superficial bladder tumors.
Cordon-Cardo C, Wartinger DD, Melamed MR, Fair W, Fradet Y. Cordon-Cardo C, et al. Am J Pathol. 1992 Feb;140(2):375-85. Am J Pathol. 1992. PMID: 1739131 Free PMC article.
Ras p21 overexpression is a late event in prostate-cancer.
Hamdy S, Aprikian A, Begin L, Fair W, Bazinet M. Hamdy S, et al. Int J Oncol. 1994 Mar;4(3):627-31. doi: 10.3892/ijo.4.3.627. Int J Oncol. 1994. PMID: 21566969
Monoclonal-antibody pd-41 recognizes a prostate-cancer associated antigen whose expression increases in metastases and following hormonal-therapy.
Bazinet M, Hamdy S, Begin L, Aprikian A, Fair W, Wright G. Bazinet M, et al. Int J Oncol. 1995 Dec;7(6):1421-5. doi: 10.3892/ijo.7.6.1421. Int J Oncol. 1995. PMID: 21552982
301 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page